CrossrefInfokarte
Weight Loss Effect of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Patients with Obesity without Diabetes: a Systematic Review
Acta Endocrinologica (Bucharest) · 2022 · 18 (2) · 216-224
DOI: 10.4183/aeb.2022.216 ↗Abstract
Kein Abstract verfügbar.
EUVIMED